[EN] 2,3-DISUBSTITUTED PYRIDINE COMPOUNDS AS TGF-BETA INHIBITORS AND METHODS OF USE<br/>[FR] COMPOSÉS DE PYRIDINE 2,3-DISUBSTITUÉS UTILISÉS COMME INHIBITEURS DE TGF-BÊTA ET PROCÉDÉS D'UTILISATION
申请人:RIGEL PHARMACEUTICALS INC
公开号:WO2015157093A1
公开(公告)日:2015-10-15
The invention described herein comprises compounds of formula (IV) and a method of treating cancer comprising administering to a subject having cancer one of the compounds in conjunction with another therapeutic treatment of cancer. The compounds (IV) inhibit signaling by a member of the TGF-β superfamily such as Nodal or Activin.
本发明涉及的化合物包括公式(IV)的化合物,以及一种治疗癌症的方法,包括向患有癌症的受试者施用其中一种化合物,结合另一种癌症治疗方法。这些化合物(IV)抑制TGF-β超家族成员如Nodal或Activin的信号传导。